SEC Tracker
Get the app

Possible new Bioventus shares

BVSDilution

Known so far: no new shares from the prospectus covers read · shelf not limited by the baby-shelf rule · not yet read: warrants, converts, ATM.

Shelf room

  • Room today not capped by the baby-shelf rule ($264M float, Jun 28, 2025)
How this is worked out

Shelf room on the S-3 of Oct 25, 2024: not limited by the baby-shelf rule, because the $264M public float stated as of Jun 28, 2025 is $75M or more. Sources: S-3 Oct 25, 2024, effective Nov 4, 2024 · public float, as of Jun 28, 2025.

What could become new Bioventus (BVS) shares: options and RSUs, each with the 10-Q, 10-K, S-3 or 424B filing it comes from.

Bioventus dilution ladder

Every source of new shares on record, from the filings that created it.

84.3M outstanding; up to 93.2M fully diluted, +11%

  1. Outstandingas of Oct 23, 2026 (10-Q filed Nov 2) · share count on the cover page
    84.3M
  2. Options and RSUs5.3M options, 3.6M RSUs10-Q Nov 2, 2026 · equity note
    +8.9M

Not stated in the filings we read: an ATM program, warrants, convertible notes.

Counts, sizes and prices as stated in each filing; the fully diluted count is arithmetic on them. Dollars become shares only at a price a filing states. Not advice.

Financing terms to know

None found in filings since Nov 2, 2026.

Each term is quoted from the exhibit it comes from; numbers are as stated in the filing. A flag describes a financing term. It is not investment advice.